Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRACLE: Benralizumab in Uncontrolled Asthma
NCT03186209Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2017
- Primary completion
- Jan 2023
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 3 trial of benralizumab in asthma, sponsored by AstraZeneca. Started Sep 2017; status: completed.
02
Drugs
benralizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03186209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03186209.